7,8-Dihydroxyflavone is a plant molecule that switches on the same brain receptor as a natural growth protein. Animal studies fairly consistently show better memory, neuron protection, and improved mood, with weaker signals elsewhere. No completed human trials exist, so every benefit and dose is estimated from rodents. Promising but essentially unproven in people. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT & AST | ~10–26 U/L | Screen liver stress from a compound cleared by the liver |
| Vitamin B6 (pyridoxal 5'-phosphate) | ~30–80 nmol/L | Detect disruption from pyridoxal phosphatase inhibition |
| Complete blood count | Within standard reference limits | Baseline safety screen for an untested agent |
| Fasting glucose & HbA1c | Glucose ~75–90 mg/dL; HbA1c <5.4% | Track the metabolic effects suggested in animal studies |
| Comprehensive metabolic panel | Within standard reference limits | Monitor kidney function and electrolytes over time |
Cadence: Baseline before first dose; repeat at ~3 months, then every 6–12 months (sooner if any symptom arises)